Research & Publications


1. Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG, Jenkins M, et al. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care. BMC Medical Informatics and Decision Making. 2017;17(1):13.


1.  Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, et al. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. International journal of epidemiology. 2016.
2.  Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmana J, et al. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. Journal of the National Cancer Institute. 2016;108(2).
3.    Jenkins MA, Makalic E, Dowty JG, Schmidt DF, Dite GS, MacInnis RJ, et al. Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. Future oncology. 2016;12(4):503-13.
4.    Usher-Smith JA, Walter FM, Emery JD, Win AK, Griffin SJ. Risk Prediction Models for Colorectal Cancer: A Systematic Review. Cancer prevention research. 2016;9(1):13-26.


1.    Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. Bmj. 2015;351:h4970.
2.    Chiang PPC, Glance D, Walker J, Walter FM, Emery JD. Implementing a QCancer® risk tool into General practice consultations: an Exploratory study using simulated consultations with Australian General Practitioners. British Journal of Cancer, 2015 112:S77-S83.
3.    Jenkins MA, Dowty JG, Ait Ouakrim D, Mathews JD, Hopper JL, Drouet Y, et al. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(4):326-31.
4.    Reid GT, Walter FM, Emery JD. A qualitative evaluation of the psychosocial impact of family history screening in Australian primary care. Journal of genetic counseling. 2015;24(2):312-24.
5.    Walker J, Licqurish S, Chiang PPC, Pirotta M, Emery JD. Cancer Risk Assessment Tools in Primary Care: A Systematic Review of Randomized Controlled Trials. Annals of Family Medicine, 2015 13:5, pages 480-489.
6.    Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, et al. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut. 2015;64(1):101-10.
7.    Win AK, Clendenning M, Crawford W, Rosty C, Preston SG, Southey MC, et al. Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome. Genes & cancer. 2015;6(11-12):445-51.


1.    Buchanan DD, Rosty C, Clendenning M, Spurdle AB, Win AK. Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome). The application of clinical genetics. 2014;7:183-93.
2.    Emery J, Chiang P. The role of risk tools in diagnosing cancer in primary care. Australian family physician. 2014;43(8):508-12.
3.    Flander L, Speirs-Bridge A, Rutstein A, Niven H, Win AK, Ait Ouakrim D, et al. Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing. Journal of genetic counseling. 2014;23(1):79-88.
4.    Newton K, Jorgensen NM, Wallace AJ, Buchanan DD, Lalloo F, McMahon RF, et al. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). Journal of medical genetics. 2014;51(12):789-96.
5.    Ouakrim DA, Boussioutas A, Lockett T, Hopper JL, Jenkins MA. Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC cancer. 2014;14:261.
6.    Plazzer JP, Macrae F. DNA variant databases: current state and future directions. Methods in molecular biology. 2014;1168:263-73.
7.    Rosty C, Williamson EJ, Clendenning M, Walters RJ, Walsh MD, Win AK, et al. Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. Journal of the National Cancer Institute. 2014;106(8).
8.    Stupart D, Win AK, Jenkins M, Winship IM, Goldberg P, Ramesar R. Fertility and apparent genetic anticipation in Lynch syndrome. Familial cancer. 2014;13(3):369-74.
9.    Whiffin N, Hosking FJ, Farrington SM, Palles C, Dobbins SE, Zgaga L, et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Human molecular genetics. 2014;23(17):4729-37.
10.    Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014;146(5):1208-11 e1-5.